FDA: In-Vitro Alcohol testing of modified release product [Regulatives / Guidelines]

posted by jag009  – NJ, 2012-05-16 18:22 (5139 d 09:01 ago) – Posting: # 8577
Views: 2,844

Hi everyone,

Does anyone have experience with the in-vitro EtOH testing on modified release drug product as per FDA for the assessment of dose dumping? Is it required to compare against the reference product? If so, is it based on f2?

If the rate of in-vitro release in EtOH is not similar (i.e., faster but not the point of dose dumping) to that of the reference, then what?

Thanks

John

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
144 visitors (0 registered, 144 guests [including 57 identified bots]).
Forum time: 03:23 CEST (Europe/Vienna)

Outside his own ever-narrowing field of specialization,
a scientist is a layman.
What members of an academy of science have in common
is a certain form of semiparasitic living.    Erwin Chargaff

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5